- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Basit Chaudhry: Feedback Provides Potential Changes for the OCM
Basit Chaudhry, MD, PhD, founder of Tuple Health, discussed the feedback he's heard from practices about the Oncology Care Model and how these opinions could be used to guide potential changes.
Basit Chaudhry, MD, PhD, founder of Tuple Health, discussed the feedback he's heard from practices about the Oncology Care Model and how these opinions could be used to guide potential changes.
Transcript (slightly modified)
Based on feedback from participating practices, are there changes you think should be made to the Oncology Care Model?
Yes, I think one of the areas where we’ve gotten a lot of feedback on is data reporting requirements on both the quality measures and the clinical measures. I think it’s a fundamentally important idea in measuring quality and also the clinical data, this makes sense, but I think the burden has been significant for practices.
Medicare’s tried to improve that, particularly changing the timelines for reporting requirements, but I think moving that forward would be important, particularly prioritizing which kind of data is really going to be the key to moving value-based payment forward in oncology. I think it would reduce the kind of challenges that participants are facing.
A second area would be to continue to evolve and improve the risk adjustment model and the prediction model in OCM, to make sure that’s clinically informed as possible and really reflects the complexity of the different patients that practices take care of, I think is very important.
I think a third thing we’ve heard about quite often is just complexities that are arising around model overlap between OCM and other payment models that Medicare is putting into place, particularly around MACRA and MIPS.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
